Economic Surge Ahead: Periodontal Treatment Market Set to Exceed US$12.2 Billion by 2031

The global periodontal treatment market is poised for substantial growth, fueled by a surge in oral health issues worldwide. With a value of US$7.6 billion in 2021, the industry is projected to achieve a CAGR of 4.8% from 2022 to 2031, reaching an impressive valuation of over US$12.2 billion by the end of the forecast period. This expansion is propelled by factors such as the escalating prevalence of periodontal diseases, technological advancements, innovative treatment product developments, and increased government funding in medical device innovation.

𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗮 𝘀𝗮𝗺𝗽𝗹𝗲 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗿𝗲𝗽𝗼𝗿𝘁 𝗮𝘁 (𝗨𝘀𝗲 𝗖𝗼𝗿𝗽𝗼𝗿𝗮𝘁𝗲 𝗠𝗮𝗶𝗹 𝗜𝗱 𝗳𝗼𝗿 𝗤𝘂𝗶𝗰𝗸 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗲) -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85283&utm_source=OpenPR_Ajay&utm_medium=OpenPR

𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗣𝗲𝗿𝗶𝗼𝗱𝗼𝗻𝘁𝗮𝗹 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁

Periodontal diseases, impacting the gums and bone surrounding teeth, encompass gingivitis and the more severe periodontitis. Gingivitis presents as swollen, red, and bleeding gums, while periodontitis involves gum recession, bone loss, and the potential loss of teeth. These disorders mainly affect adults and pose significant threats to dental health, contributing to conditions like stroke, heart disease, diabetes, and respiratory issues. Timely and effective periodontal therapy can prevent invasive treatments in the long run.

𝗙𝗮𝗰𝘁𝗼𝗿𝘀 𝗗𝗿𝗶𝘃𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝗚𝗿𝗼𝘄𝘁𝗵

Rising Disease Prevalence: A staggering 90% of the global population is affected by periodontal diseases, according to the World Health Organization (WHO). The Centers for Disease Control and Prevention reports that over 42% of adults aged 30 and above in the U.S. suffer from periodontal disease. As such, the demand for treatment is on the rise, boosting the market's growth trajectory.

Lifestyle and Habits: Unhealthy dietary habits, sedentary lifestyles, and smoking contribute significantly to periodontal diseases. Processed foods and refined carbohydrates elevate gum inflammation, while smoking exacerbates periodontitis and makes it less responsive to treatment. Moreover, stress weakens the immune system, rendering gums more susceptible to harmful bacteria.

Non-Surgical Treatment Preference: Non-surgical treatment methods, including scaling and root planning, as well as antibiotic therapies, are more popular than surgical alternatives due to their minimally invasive nature, reduced pain, and shorter recovery times.

Dental Clinic Preference: Dental clinics are the preferred choice for treating dental-related issues. The convenience and expertise offered by these clinics have driven a surge in treatments in this setting.

𝗕𝘂𝘆 𝘁𝗵𝗶𝘀 𝗣𝗿𝗲𝗺𝗶𝘂𝗺 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 | 𝗜𝗺𝗺𝗲𝗱𝗶𝗮𝘁𝗲 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗔𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗮𝘁 -

https://www.transparencymarketresearch.com/checkout.php?rep_id=85283<ype=S&utm_source=OpenPR_Ajay&utm_medium=OpenPR

𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗧𝗿𝗲𝗻𝗱𝘀

North America: Leading the market in 2021, North America benefits from robust scientific research, technological advancements, and an increasing scope for periodontal treatment development. The prevalence of periodontal disease in the U.S. is significant, with over 47% of adults aged 30 and above affected.

Asia Pacific: This region is expected to experience the highest CAGR during the forecast period, attributed to a rising prevalence of oral diseases, increased awareness, growing adoption of periodontal treatment, and governmental support.

𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗮𝗻𝗱 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁𝘀

Key players in the periodontal treatment market are channeling resources into research and development for advanced treatment solutions. Expansion of product portfolios and mergers and acquisitions are common strategies. Notable companies include Amyndas Pharmaceuticals, 3M, Dentsply Sirona, and Novartis AG.

𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗰𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗿𝗲𝗽𝗼𝗿𝘁 𝗮𝘁 -

https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=85283&utm_source=OpenPR_Ajay&utm_medium=OpenPR

𝗥𝗲𝗰𝗲𝗻𝘁 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗶𝗻𝗰𝗹𝘂𝗱𝗲:

Biocomposites partnering with Zimmer Biomet to distribute genex Bone Graft Substitute in the U.S.
Envista Holdings renewing its partnership agreement with the Vitaldent Group for the supply of implants and clear aligners.
Positive phase 2 results announced by Amyndas Pharmaceuticals for their trial evaluating AMY-101 in patients with periodontitis and gingivitis.

𝗠𝗼𝗿𝗲 𝗧𝗿𝗲𝗻𝗱𝗶𝗻𝗴 𝗥𝗲𝗽𝗼𝗿𝘁𝘀 𝗯𝘆 𝗧𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝗰𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 -

Healthcare Biometrics for Children Market

https://www.globenewswire.com/en/news-release/2022/08/03/2491659/0/en/Healthcare-Biometrics-for-Children-Market-to-Reach-US-1-30-Bn-by-2031-TMR-Report.html

Pharmaceutical Contract Sales Outsourcing [CSO] Market

https://www.globenewswire.com/en/news-release/2022/08/02/2490622/0/en/Pharmaceutical-Contract-Sales-Outsourcing-CSO-Market-Attracts-Notable-Growth-Prospects-due-to-Expansion-of-Pharmaceutical-Industry-States-TMR-Study.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.